“If we authorize marketing, it is because we have sufficient confidence”

The arrival of a first vaccine seems imminent. The American laboratory Pfizer announced on Wednesday November 18 that his solution was 95% efficiency, therefore slightly more than the Modern, 94.5% effective. This breed of vaccines can create a little skepticism, which makes one wonder if all this would not have been messed up for the benefit of financial interests.

For Professor Bruno Hoen, guest of RTL, this idea seems absurd, “if we authorize the commercialization of a vaccine, is that you have a guarantee, sufficient confidence in your own safety“Regarding the possible unexpected side effects, the director of medical research at the Institut Pasteur goes on to explain that it is” quite rare that there are late side effects“.

“This will be the first criterion, make sure there are no side effects with an unacceptable frequency or severity and it is sufficiently protective“, he continues. To do this, each country has its own pharmaceutical agency, independent of any authority”, so if a vaccine is placed on the market, we will have considered that its safety and efficacy are very satisfactory“.

Read more